Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice

Adenosine deaminase (ADA)-deficient mice and healthy rhesus monkeys were studied to determine the impact of age at treatment, vector dosage, dosing schedule, repeat administration, biodistribution, and immunogenicity after systemic delivery of lentiviral vectors (LVs). In Ada(−/−) mice, neonatal tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbonaro-Sarracino, Denise A., Tarantal, Alice F., Lee, C. Chang I., Kaufman, Michael L., Wandro, Stephen, Jin, Xiangyang, Martinez, Michele, Clark, Danielle N., Chun, Krista, Koziol, Colin, Hardee, Cinnamon L., Wang, Xiaoyan, Kohn, Donald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909201/
https://www.ncbi.nlm.nih.gov/pubmed/31871959
http://dx.doi.org/10.1016/j.omtm.2019.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909201/
https://www.ncbi.nlm.nih.gov/pubmed/31871959
http://dx.doi.org/10.1016/j.omtm.2019.11.004

Ejemplares similares